healthcare

Long Island Man Sebastien Beauzile Becomes First New Yorker Cured of Sickle Cell Disease With Lyfgenia Gene Therapy
Health News

Long Island Man Sebastien Beauzile Becomes First New Yorker Cured of Sickle Cell Disease With Lyfgenia Gene Therapy

Sebastien Beauzile, 21, received Lyfgenia at Cohen Children's Medical Center and is free of sickle cell pain. The $3.1 million therapy still reaches only a handful of patients.
Australian Man Walks Out of Hospital With a Titanium BiVACOR Heart After 100 Days Awaiting Transplant
News

Australian Man Walks Out of Hospital With a Titanium BiVACOR Heart After 100 Days Awaiting Transplant

A man in his forties lived more than 100 days on a magnetically levitated titanium heart, then received a donor organ. Two later Australian patients died of brain bleeds.
UnitedHealthcare Called Surgeon Elisabeth Potter During an Operation, Then Fought Her After She Posted the Call
News

UnitedHealthcare Called Surgeon Elisabeth Potter During an Operation, Then Fought Her After She Posted the Call

Prior authorization walked into a room that should have one voice. Potter posted the interruption. The company later advertised that it would cut more of those reviews.
Delaware Driver April Love Crashes a Kia Sixty Feet Into the Inspira Emergency Ambulance Bay in Bridgeton on New Year’s Eve
Crime News

Delaware Driver April Love Crashes a Kia Sixty Feet Into the Inspira Emergency Ambulance Bay in Bridgeton on New Year’s Eve

Police say April Love of New Castle drove through Inspira Bridgeton's ambulance doors about 11:35 p.m. on December 31, 2024. A security officer jumped clear.
Cancer Drugs Targeting IDO1 And Approved Antibody Kisunla Offer Separate Paths For People Facing Early Alzheimer’s Disease
Health News

Cancer Drugs Targeting IDO1 And Approved Antibody Kisunla Offer Separate Paths For People Facing Early Alzheimer’s Disease

Eli Lilly's Kisunla won FDA approval on July 2, 2024, an EU authorization in September 2025, and a slower-titration label in July 2025 that cut ARIA-E. A 2024 Science paper…
Bouton retour en haut de la page